ABBV-509

Systemic lupus erythematosus: major drug trials to watch in 2022 and 2023
Clinical Trials Arena
Mon, 10/31/22 - 10:37 am
clinical trials
systemic lupus erythematosus
AbbVie
ABBV-509
Eli Lilly
LY3471851
Merck KGaA
M5049
Swedish Orphan Biovitrum
emapalumab